Rockefeller Capital Management
ETNB

Rockefeller Capital Management’s 89bio ETNB Stock Holding History

Rockefeller Capital Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,000
Closed -$12K – 2562
2022
Q4 		$12K Hold
1,000
– – ﹤0.01% 2998
2022
Q3 		$5K Hold
1,000
– – ﹤0.01% 3329
2022
Q2 		$3K Hold
1,000
– – ﹤0.01% 3636
2022
Q1 		$3K Buy
+1,000
New +$6.44K ﹤0.01% 3494

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Rockefeller Capital Management's ETNB Position: Q1 2023 in Review

Rockefeller Capital Management sold out of 89bio (ETNB) in Q1 2023, closing a stake of 1,000 shares — an estimated $12K sold.

Rockefeller Capital Management first reported a position in ETNB in Q1 2022 and held it in 4 quarters. The position peaked at $12K in Q4 2022. 145 funds tracked by Wall St. Rank hold ETNB as of Q1 2023.

  • Rockefeller Capital Management reported no remaining 89bio position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 1,000 89bio shares in Q1 2023, an estimated $12K.
  • Rockefeller Capital Management first reported a position in 89bio in Q1 2022 and held it in 4 quarters.
  • Rockefeller Capital Management's 89bio position peaked at $12K in Q4 2022.
  • 145 funds tracked by Wall St. Rank held 89bio as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.